日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

US FDA issues emergency use authorization for first COVID-19 vaccine

Xinhua | Updated: 2020-12-12 14:08
Share
Share - WeChat
In this file photo illustration taken on Nov 23, 2020, shows a syringe and a bottle reading "COVID-19 Vaccine" next to the Pfizer company logo. [Photo/Agencies]

WASHINGTON -- The US Food and Drug Administration (FDA) Friday issued authorization for emergency use of the first COVID-19 vaccine in the United States.

The first Emergency Use Authorization (EUA) was issued to the COVID-19 vaccine of American drugmaker Pfizer in partnership with German company BioNTech, allowing the vaccine to be distributed in the United States.

The FDA has determined that Pfizer-BioNTech COVID-19 vaccine has met the statutory criteria for issuance of an EUA. The totality of the available data provides clear evidence that Pfizer-BioNTech COVID-19 vaccine may be effective in preventing COVID-19, said the FDA in a statement.

The data also show that the known and potential benefits outweigh the known and potential risks, supporting the vaccine's use in millions of people 16 years of age and older, said the FDA.

"The FDA's authorization for emergency use of the first COVID-19 vaccine is a significant milestone in battling this devastating pandemic that has affected so many families in the United States and around the world," said FDA Commissioner Stephen Hahn.

"Today's action follows an open and transparent review process that included input from independent scientific and public health experts and a thorough evaluation by the agency's career scientists to ensure this vaccine met FDA's rigorous, scientific standards for safety, effectiveness, and manufacturing quality needed to support emergency use authorization," he said in a statement.

The Pfizer-BioNTech vaccine contains a small piece of the SARS-CoV-2 virus's mRNA that instructs cells in the body to make the virus's distinctive "spike" protein.

When a person receives this vaccine, their body produces copies of the spike protein, which does not cause disease, but triggers the immune system to learn to react defensively, producing an immune response against SARS-CoV-2.

The vaccine is administered as a series of two doses, three weeks apart.

Global COVID-19 cases surpassed 70 million on Friday, according to the Center for Systems Science and Engineering at Johns Hopkins University. The United States reported the most cases and deaths around the world as of 4:28 pm local time (2128 GMT), numbering 15,758,661 and 293,785, respectively.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 大开眼界电影完整在线看 | 五月天婷婷免费观看视频在线 | 天天噜夜夜操 | 99久久久国产精品露出 | 精品久久久久久亚洲综合网 | www.sewang| 国产精品久久久久无码AV1 | 国产欧美一区二区成人影院 | 狠狠色狠狠色综合日日92 | 亚洲一区二区在线视频 | 国产精品99久久久久久www | 日韩欧美国内 | 精品国产第一国产综合精品 | 韩国精品在线 | 看一天影院宅急看在线观看 | 男女午夜视频 | 久热国产精品视频 | 很黄很暴力深夜爽爽无遮挡 | 91视频精选 | 日韩在线看片 | 成人久久一区二区 | 加勒比色| 狠狠插综合 | 精品国产18久久久久久二百 | 久久草视频这里只精品 | 老版亮剑50集免费观看 | 日日摸夜夜添夜夜添破第一 | 欧美区一区二区三 | 欧美精品综合一区二区三区 | 成人天堂资源www在线 | 欧美一级二级三级 | 欧洲一级毛片 | 欧美视频一区 | 国产精品视频99 | 日韩欧美在线视频不卡免费视频 | 国产1区2 | 欧美激情一区二区三级高清视频 | 五月天色婷婷在线 | 婷婷黄色| 2018天天干夜夜操 | 中文字幕精品视频 |